Company Overview and News

KLCI pares gains as Trump threatens more tariffs on China

2018-10-15 theedgemarkets
KUALA LUMPUR (Oct 15): The FBM KLCI pared some of its gains at midday break, as regional markets remained jittery with U.S.President Donald Trump threatening to impose another round of tariffs on China.
HLFBF 5183 PECGF 1082 7113 5681 TPGVF 7006 5168 5014 9334 6033 5199 TGLVY 5238 4588 PNADF MYPRY HIPEF PNAGF HRGHY

KLCI up 0.79% in technical rebound, Maybank and TNB lift

2018-10-12 theedgemarkets
KUALA LUMPUR (Oct 12): The FBM KLCI rose 0.79% in a technical rebound at the midday break today, snapping its seven-day losing streak, lifted by index heavyweights including Malayan Banking Bhd (Maybank) and Tenaga Nasional Bhd (TNB).
HLFBF MLYBY MLYNF 7036 1082 7006 5135 6033 5199 CIMDF 1155 KLKBY 1023 2445 PNADF 5347 TNABY 6888 0006 5819 AXXTF TNABF HIPEF PNAGF

KLCI to trade range bound, hover around 1,800-level

2018-09-17 theedgemarkets
KUALA LUMPUR (Sept 18): The FBM KLCI is expected trade range bound today and hover around the 1,800-point level today, given the positive domestic sentiment after Morgan Stanley last week upgraded Malaysia stocks to equal weight
GMALF 7006 9598 GMALY 4995 4715 7208 MS

Tropicana, Latitude Tree, Versatile Creative, Vertice, Euro Holdings, Genting Malaysia, Gamuda and Pintaras Jaya

2018-09-14 theedgemarkets
KUALA LUMPUR (Sept 14): Based on corporate announcements and news flow today, companies that may be in focus on Tuesday (Sept 18) may include the following: Tropicana Corp Bhd, Latitude Tree Holdings Bhd, Versatile Creative Bhd, Vertice Bhd, Euro Holdings Bhd, Genting Malaysia Bhd, Gamuda Bhd and Pintaras Jaya Bhd.
GMALY 4995 4715 GMALF 7208 7006 BSMAF 9598 1818

Latitude Tree leases land in Vietnam for expansion

2018-09-14 theedgemarkets
KUALA LUMPUR (Sept 14): Latitude Tree Holdings Bhd is leasing a parcel of land measuring about 44,193 square metres in Binh Duong province, Vietnam, as preparation for expansion.
7006 BSMAF 1818

Worst is over for Latitude Tree, says director

2018-08-20 theedgemarkets
KUALA LUMPUR: In less than two weeks, Latitude Tree Holdings Bhd is going to publish its unaudited financial results for the fourth quarter ended June 30, 2018 (4QFY18), but finance director Yeoh Joe Son expects the final quarter’s earnings will not be able to salvage the group’s lacklustre performance for the fiscal year, which he has termed the group’s “worst”.

Shares of furniture players gain on potential increase in demand amid US-China trade war

2018-07-23 theedgemarkets
KUALA LUMPUR (July 23): Interest in shares of export-oriented furniture manufacturers spiked, following news the United States is looking to impose a 10% tariff on more than 5,000 new Chinese imports worth US$200 billion, which includes furniture.
7006 7088 5101 LIIHF 5001

KLCI pares loss as foreign selling slows down

2018-07-23 theedgemarkets
KUALA LUMPUR (July 23): The FBM KLCI pared some of its losses at midday break today, despite weaker regional markets, as foreign selling of local equities remained measured for the fourth week running.
HLFBF 7172 UPBMF 1082 BATS 4162 7006 2089 7055 LIIHF KLKBY 5238 2445 4588 3867 5738 0026

KLCI dips 0.24% in line with regional markets

2018-07-23 theedgemarkets
KUALA LUMPUR (July 23): The FBM KLCI dipped 0.24% at mid-morning today, tracking regional losses, weighed by select index-linked blue chips.
7172 UPBMF 7006 2089 5014 9334 6033 5101 LIIHF 7123 KLKBY 5238 2445 4588 PNADF 5738 7216 0026 MYPRY 2836 PNAGF

Furniture and glove makers winners in US-China trade war

In the rubber glove sector, possible winners (but receiving only minimal spillover benefits) are Top Glove Corp Bhd, Hartalega Holdings Bhd and Kossan Rubber Industries Bhd.
TGLVY 7113 TPGVF 7006 7153 5168 7022 5101 GBTKF LIIHF HRGHY 5001

LSK aims to double sales by 2020 with MFO in its stable

Lee Swee Kiat (LSK) Group Berhad managing director Eric Lee will the range of Napure Mattresses.
7006 BSMAF 7088 8079 LIIHF 1818

Trading ideas: Magnum, Sunway, Deleum, PetChem, BAT

KUALA LUMPUR: JF Apex Research expects Magnum Bhd , Sunway Bhd , Deleum Bhd , Petronas Chemicals Groups Bhd (PetChem) and British American Tobacco (BAT) to be among the stocks to watch today.
BATS 4162 7006 3719

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...